Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,128 public trials 361 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

NCT05514509

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Miami, Florida, United States
View all 22 locations
View Trial Details
Completed

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

NCT05119855

Conditions
COVID-19, Communicable Diseases, Coronaviridae Infections, +21 more
Locations
  • Cognitive Clinical Trials, LLC ( Site 0054) Phoenix, Arizona, United States
  • Eclipse Clinical Research ( Site 0095) Tucson, Arizona, United States
  • Children's Clinic of Jonesboro, PA ( Site 0044) Jonesboro, Arkansas, United States
  • Preferred Research Partners Inc. ( Site 0092) Little Rock, Arkansas, United States
View all 38 locations
View Trial Details
Completed

Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

NCT03016533

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Memphis, Tennessee, United States
  • GSK Investigational Site Gaborone, Botswana
View all 17 locations
View Trial Details

Related conditions